Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Though it is a rare condition, tirzepatide-related pancreatitis can manifest as severe abdominal pain, fever, nausea, and vomiting
The study indicates there's potential to study the effects of semaglutide for TUD treatment
Mounjaro (tirzepatide) produces greater average weight loss in clinical trials (~21% vs ~15% for Wegovy), while Wegovy offers the branded assurance of a single-indication, FDA-obesity-approved medication from Novo Nordisk
If you have documented cardiovascular disease such as a history of heart attack, stroke, or peripheral arterial disease your clinician may be able to submit the prior authorization under the cardiovascular indication rather than the chronic weight management indication
doi:10.1172/JCI114666
What do we know about its safety profile
